INTG
The InterGroup Corporation
INTG has a slight edge over LCID overall, supported by stronger fundamentals.
LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
INTG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
INTG's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
INTG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 28x | $19.82 | -51% |
| Fair | 35x | $24.84 | -38% |
| Current | 56x | $40.10 | — |
| Expensive | 83x | $59.17 | +48% |
Historical ranges are pointers, not guarantees.
INTG's PE is in its expensive range at 56x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
INTG Forward outlook
There aren't enough analyst estimates for INTG to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
INTG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.71 | +$3.18 |
| Q1 2026 | -$0.09 | +$3.38 |
| Q4 2025 | -$0.57 | +$4.07 |
| Q3 2025 | -$2.54 | +$1.53 |
| Q2 2025 | -$2.47 | +$1.98 |
| Q1 2025 | -$3.47 | +$2.86 |
| Q4 2024 | -$4.64 | +$0.41 |
| Q3 2024 | -$4.07 | -$0.48 |
INTG has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
INTG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $18.4M | +13% |
| Q1 2026 | $20.4M | +21% |
| Q4 2025 | $17.3M | +20% |
| Q3 2025 | $17.9M | +6% |
| Q2 2025 | $16.2M | +21% |
| Q1 2025 | $16.8M | +13% |
| Q4 2024 | $14.4M | +0.8% |
| Q3 2024 | $16.9M | +9% |
INTG's revenue has grown year over year for 11 quarters in a row: $18M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 16% | +7.5 points |
| Q1 2026 | 21% | +6.9 points |
| Q4 2025 | 12% | +5.7 points |
| Q3 2025 | 15% | -3.3 points |
| Q2 2025 | 8.1% | +4.4 points |
| Q1 2025 | 14% | +9.2 points |
| Q4 2024 | 5.9% | +15 points |
| Q3 2024 | 19% | +8.2 points |
INTG has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over INTG on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
INTG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $368K | -87% |
| Q1 2026 | $2.6M | +$3.8M |
| Q4 2025 | -$481K | +$646K |
| Q3 2025 | -$1.3M | -141% |
| Q2 2025 | $2.8M | -21% |
| Q1 2025 | -$1.2M | -202% |
| Q4 2024 | -$1.1M | +$2M |
| Q3 2024 | $3.1M | +169% |
INTG has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
INTG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | 13.0x | High |
| Q4 2025 | 15.0x | High |
| Q3 2025 | 16.8x | High |
| Q2 2025 | 16.5x | High |
| Q1 2025 | 17.7x | High |
| Q4 2024 | 18.5x | High |
| Q3 2024 | 22.5x | High |
INTG has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
INTG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 84.6 | Overbought |
INTG's weekly RSI is 56 (neutral) and its Stochastic is 85 (overbought).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
INTG PE vs Consumer Cyclical Sector
| Metric | INTG | Sector median | Relative |
|---|---|---|---|
| PE | 56x | 18x | 213% above |
| PE % | 78 | 47 | 31 pts above |
INTG is trading at 56x earnings, a 213% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
INTG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.7 | 16% above |
| 20 week MA | $35.6 | 13% above |
| 50 week MA | $34.4 | 17% above |
| 100 week MA | $25.5 | 57% above |
| 200 week MA | $26.3 | 53% above |
INTG has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
INTG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.2 | $33.3 | -10% |
| 2021 | $33.3 | $47.5 | +42% |
| 2022 | $47.5 | $49.5 | +4.3% |
| 2023 | $49.5 | $19.7 | -60% |
| 2024 | $19.7 | $14.3 | -27% |
| 2025 | $14.3 | $27.3 | +91% |
| 2026 YTD | $27.3 | $40.1 | +47% |
INTG has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.